A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.
Osteoporos Int. 2022 Jan;33(1):1-12. doi: 10.1007/s00198-021-06095-y. Epub 2021 Aug 25.
Osteoporos Int. 2022.
PMID: 34432115
Free PMC article.
Review.